| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |